X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs SHASUN PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD SHASUN PHARMA WYETH LTD/
SHASUN PHARMA
 
P/E (TTM) x 27.7 123.9 22.4% View Chart
P/BV x 5.3 8.5 62.7% View Chart
Dividend Yield % 1.3 0.2 546.3%  

Financials

 WYETH LTD   SHASUN PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
SHASUN PHARMA
Mar-14
WYETH LTD/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs1,04494 1,108.7%   
Low Rs81846 1,793.9%   
Sales per share (Unadj.) Rs298.6214.2 139.4%  
Earnings per share (Unadj.) Rs57.25.3 1,072.7%  
Cash flow per share (Unadj.) Rs58.415.8 369.2%  
Dividends per share (Unadj.) Rs17.001.00 1,700.0%  
Dividend yield (eoy) %1.81.4 127.6%  
Book value per share (Unadj.) Rs249.553.3 467.7%  
Shares outstanding (eoy) m22.7256.62 40.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.10.3 955.7%   
Avg P/E ratio x16.313.1 124.2%  
P/CF ratio (eoy) x15.94.4 360.8%  
Price / Book Value ratio x3.71.3 284.8%  
Dividend payout %29.718.7 158.5%   
Avg Mkt Cap Rs m21,1573,958 534.6%   
No. of employees `0000.5NA-   
Total wages/salary Rs m4002,164 18.5%   
Avg. sales/employee Rs Th13,787.4NM-  
Avg. wages/employee Rs Th813.0NM-  
Avg. net profit/employee Rs Th2,643.3NM-  
INCOME DATA
Net Sales Rs m6,78312,127 55.9%  
Other income Rs m353229 153.7%   
Total revenues Rs m7,13612,356 57.8%   
Gross profit Rs m1,6171,009 160.3%  
Depreciation Rs m27594 4.5%   
Interest Rs m6415 1.3%   
Profit before tax Rs m1,938230 843.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m-50-   
Tax Rs m632-73 -869.4%   
Profit after tax Rs m1,301302 430.5%  
Gross profit margin %23.88.3 286.5%  
Effective tax rate %32.6-31.7 -103.1%   
Net profit margin %19.22.5 769.5%  
BALANCE SHEET DATA
Current assets Rs m6,9846,884 101.4%   
Current liabilities Rs m2,0568,456 24.3%   
Net working cap to sales %72.6-13.0 -560.6%  
Current ratio x3.40.8 417.2%  
Inventory Days Days9962 161.1%  
Debtors Days Days24108 22.3%  
Net fixed assets Rs m2444,970 4.9%   
Share capital Rs m227113 200.5%   
"Free" reserves Rs m5,4412,875 189.3%   
Net worth Rs m5,6683,020 187.7%   
Long term debt Rs m251,817 1.4%   
Total assets Rs m7,90113,347 59.2%  
Interest coverage x353.31.6 22,746.0%   
Debt to equity ratio x00.6 0.7%  
Sales to assets ratio x0.90.9 94.5%   
Return on assets %16.55.4 307.6%  
Return on equity %22.910.0 229.4%  
Return on capital %34.013.3 255.5%  
Exports to sales %0.246.4 0.5%   
Imports to sales %36.314.2 255.1%   
Exports (fob) Rs m155,622 0.3%   
Imports (cif) Rs m2,4651,728 142.7%   
Fx inflow Rs m155,843 0.3%   
Fx outflow Rs m2,6772,173 123.2%   
Net fx Rs m-2,6623,669 -72.5%   
CASH FLOW
From Operations Rs m923398 232.2%  
From Investments Rs m317-1,635 -19.4%  
From Financial Activity Rs m-4811,309 -36.8%  
Net Cashflow Rs m75971 1,066.2%  

Share Holding

Indian Promoters % 0.0 39.2 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 3.6 313.9%  
FIIs % 7.2 17.6 40.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 39.6 76.8%  
Shareholders   21,978 20,750 105.9%  
Pledged promoter(s) holding % 0.0 12.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   CIPLA  PFIZER  ALKEM LABORATORIES  SUN PHARMA  SANOFI INDIA  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices End on a Positive Note; Banking and Healthcare Stocks Witness Buying Interest(Closing)

Indian share markets ended their session on a positive note today. Gains were largely seen in the banking sector and healthcare sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My First Pharma Stock Recommendation!(The 5 Minute Wrapup)

Sep 21, 2018

This company has not only created a niche in the pharma space, it has done so profitably.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

How IL&FS Rating Downgrade Will Impact Your Mutual Funds...(Outside View)

Sep 17, 2018

PersonalFN explains the impact of IL&FS rating downgrade on mutual funds.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD 8-QTR ANALYSIS

COMPARE WYETH LTD WITH

MARKET STATS